BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15041147)

  • 1. Ranking and prioritization of environmental risks of pharmaceuticals in surface waters.
    Sanderson H; Johnson DJ; Reitsma T; Brain RA; Wilson CJ; Solomon KR
    Regul Toxicol Pharmacol; 2004 Apr; 39(2):158-83. PubMed ID: 15041147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain).
    Ginebreda A; Muñoz I; de Alda ML; Brix R; López-Doval J; Barceló D
    Environ Int; 2010 Feb; 36(2):153-62. PubMed ID: 19931909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An exposure assessment for selected pharmaceuticals within a watershed in Southern Ontario.
    Lissemore L; Hao C; Yang P; Sibley PK; Mabury S; Solomon KR
    Chemosphere; 2006 Jul; 64(5):717-29. PubMed ID: 16403551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An environmental risk assessment for oseltamivir (Tamiflu) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions.
    Straub JO
    Ecotoxicol Environ Saf; 2009 Sep; 72(6):1625-34. PubMed ID: 19560203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity classification and evaluation of four pharmaceuticals classes: antibiotics, antineoplastics, cardiovascular, and sex hormones.
    Sanderson H; Brain RA; Johnson DJ; Wilson CJ; Solomon KR
    Toxicology; 2004 Oct; 203(1-3):27-40. PubMed ID: 15363579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceuticals in the environment: good practice in predicting acute ecotoxicological effects.
    Madden JC; Enoch SJ; Hewitt M; Cronin MT
    Toxicol Lett; 2009 Mar; 185(2):85-101. PubMed ID: 19118609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of pharmaceuticals versus industrial chemicals acute aquatic toxicity classification according to the United Nations classification system for chemicals. Assessment of the (Q)SAR predictability of pharmaceuticals acute aquatic toxicity and their predominant acute toxic mode-of-action.
    Sanderson H; Thomsen M
    Toxicol Lett; 2009 Jun; 187(2):84-93. PubMed ID: 19429249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report on interspecies quantitative correlation of ecotoxicity of pharmaceuticals.
    Kar S; Roy K
    Chemosphere; 2010 Oct; 81(6):738-47. PubMed ID: 20692010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment.
    Cooper ER; Siewicki TC; Phillips K
    Sci Total Environ; 2008 Jul; 398(1-3):26-33. PubMed ID: 18440598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system.
    Kumar A; Xagoraraki I
    Sci Total Environ; 2010 Nov; 408(23):5972-89. PubMed ID: 20869754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial ecological risk assessment of eight selected human pharmaceuticals in Japan.
    Yamamoto H; Nakamura Y; Nakamura Y; Kitani C; Imari T; Sekizawa J; Takao Y; Yamashita N; Hirai N; Oda S; Tatarazako N
    Environ Sci; 2007; 14(4):177-93. PubMed ID: 17762841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR and chemometric approaches for setting water quality objectives for dangerous chemicals.
    Vighi M; Gramatica P; Consolaro F; Todeschini R
    Ecotoxicol Environ Saf; 2001 Jul; 49(3):206-20. PubMed ID: 11440473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic aquatic environmental risks from exposure to human pharmaceuticals.
    Crane M; Watts C; Boucard T
    Sci Total Environ; 2006 Aug; 367(1):23-41. PubMed ID: 16762401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ecotoxicological quantitative structure-activity relationships for pharmaceuticals.
    Sanderson H; Thomsen M
    Bull Environ Contam Toxicol; 2007 Sep; 79(3):331-5. PubMed ID: 17701090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a novel battery of bioassays for the biological characterisation of hazardous wastes.
    Pablos MV; Fernández C; del Mar Babín M; María Navas J; Carbonell G; Martini F; García-Hortigüela P; Vicente Tarazona J
    Ecotoxicol Environ Saf; 2009 Jul; 72(5):1594-600. PubMed ID: 19217160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECOSAR model performance with a large test set of industrial chemicals.
    Reuschenbach P; Silvani M; Dammann M; Warnecke D; Knacker T
    Chemosphere; 2008 May; 71(10):1986-95. PubMed ID: 18262586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes.
    Gros M; Petrović M; Ginebreda A; Barceló D
    Environ Int; 2010 Jan; 36(1):15-26. PubMed ID: 19819553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
    Ortiz de García S; Pinto GP; García-Encina PA; Irusta Mata RI
    J Environ Manage; 2013 Nov; 129():384-97. PubMed ID: 23995140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a common priority list of pharmaceuticals relevant for the water cycle.
    de Voogt P; Janex-Habibi ML; Sacher F; Puijker L; Mons M
    Water Sci Technol; 2009; 59(1):39-46. PubMed ID: 19151484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.
    Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
    Sci Total Environ; 2006 Jul; 364(1-3):67-87. PubMed ID: 16257037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.